Bangladesh

Bangladesh beximco symptoms COVID-19 vaccine with Indian Serum Institute

Bangladesh Beximco Pharmaceuticals is investing in the Serum Institute of India (SII) to ensure that Dhaka’s priority access to COVID-19 vaccines evolved through the Indian drug manufacturer, the company announced Friday. The agreement announced through Bangladesh’s generic drug manufacturer comes after Dhaka

Bangladesh beximco symptoms COVID-19 vaccine with Indian Serum Institute Read More »